Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

Comparing Exposure v Imagery Rescripting in People With OCD: a SCED

Comparing Exposure v Imagery Rescripting in People With Obsessive Compulsive Disorder (OCD): a Single Case Experimental Design (SCED)

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Individuals with OCD may experience intrusive future orientated thoughts and images, which are extremely distressing and interfering in life. This project aims to explore whether imagery rescripting or exposure may be a more effective intervention for individuals with OCD experiencing such images.

Who May Be Eligible (Plain English)

Who May Qualify: - 18 years or over - Main diagnosis of OCD (assessed by the Structured Clinical Interview for ICD11) - Must report future orientated images that are distressing and ego-dystonic Who Should NOT Join This Trial: - Psychosis, bipolar disorder, or trauma disorder - Current stimulant or hallucinogenic misuse, alcohol or substance misuse or dependence - Intellectual disability, dementia, serious cognitive impairment, or organic brain disorder - Personality Disorder as the main problem - Active suicidality - Concurrent engagement in other psychotherapy - A patient may be taking anti-depressant medication so long as the dose has been stable for 6 weeks and there is no plan to increase the dose. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * 18 years or over * Main diagnosis of OCD (assessed by the Structured Clinical Interview for ICD11) * Must report future orientated images that are distressing and ego-dystonic Exclusion Criteria: * Psychosis, bipolar disorder, or trauma disorder * Current stimulant or hallucinogenic misuse, alcohol or substance misuse or dependence * Intellectual disability, dementia, serious cognitive impairment, or organic brain disorder * Personality Disorder as the main problem * Active suicidality * Concurrent engagement in other psychotherapy * A patient may be taking anti-depressant medication so long as the dose has been stable for 6 weeks and there is no plan to increase the dose.

Treatments Being Tested

OTHER

Imagery intervention

Imagery rescripting or imaginal exposure

Locations (1)

Centre for Anxiety Disorders and Trauma
London, United Kingdom